NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The story of KKR’s acquisition of Arctos Partners began years before the firm was founded, when one founder impressed KKR as a deal counterparty.Read More